Arcellx Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ACLX Nasdaq 8731 https://www.arcellx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arcellx Inc

Arcellx, Inc. (ACLX) Reports Q2 Loss, Misses Revenue Estimates - Aug 8th, 2024 9:25 pm
Arcellx Provides Second Quarter 2024 Financial Results and Business Updates - Aug 8th, 2024 8:00 pm
Here’s Why Arcellx (ACLX) Slipped in Q2 - Aug 2nd, 2024 10:53 am
A Look At The Intrinsic Value Of Arcellx, Inc. (NASDAQ:ACLX) - Aug 2nd, 2024 10:11 am
FDA Favorites: 3 Biotech Stocks on the Verge of Major Approvals - Jul 4th, 2024 6:13 pm
Insider Sale: CFO Michelle Gilson Sells 12,877 Shares of Arcellx Inc (ACLX) - Jun 29th, 2024 7:08 am
We Think Arcellx (NASDAQ:ACLX) Can Easily Afford To Drive Business Growth - Jun 22nd, 2024 1:18 pm
Arcellx Stock Earns Relative Strength Rating Upgrade - Jun 21st, 2024 8:42 pm
7 Biotech Stocks to Put on Your Breakthrough Radar - May 27th, 2024 4:32 pm
Insider Sale: CFO Michelle Gilson Sells Shares of Arcellx Inc (ACLX) - May 25th, 2024 7:11 am
Private Equity Prowl: 3 Overlooked Stocks Primed for Buyout Bids - May 17th, 2024 12:06 pm
Arcellx First Quarter 2024 Earnings: Beats Expectations - May 12th, 2024 12:49 pm
Arcellx Inc (ACLX) Q1 2024 Earnings: Narrower Losses and Revenue Surge - May 10th, 2024 5:13 pm
Kite and Arcellx prepare to launch Phase III multiple myeloma trial - May 10th, 2024 8:21 am
Arcellx, Inc. (ACLX) Reports Q1 Loss, Tops Revenue Estimates - May 9th, 2024 9:10 pm
Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program - May 9th, 2024 8:05 pm
Arcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program - May 9th, 2024 8:05 pm
Arcellx Provides First Quarter 2024 Financial Results - May 9th, 2024 8:00 pm
Biotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing Medicine - May 9th, 2024 10:49 am
Arcellx to Participate in Two Upcoming Investor Conferences - May 7th, 2024 8:00 pm